Chief Scientific Officer Sells Tevogen Bio Shares for Tax Obligations Neal Flomenberg, Tevogen Bio's Chief Scientific Officer, sold 232,968 shares on March 12, 2025, generating $253,935. The sale was conducted to cover tax obligations tied to restricted stock units. Despite the transaction, Flomenberg retains a significant stake in the company, with over 3.5 million shares remaining under his ownership.13